+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global eClinical Solutions Market by Product (Clinical Analytics Platforms, Clinical Data Integration Platforms, CTMS), Development Phase (Phase I, Phase II, Phase III), Delivery Mode, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337404
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The eClinical Solutions Market size was estimated at USD 9.08 billion in 2023, USD 10.40 billion in 2024, and is expected to grow at a CAGR of 15.20% to reach USD 24.46 billion by 2030.

eClinical Solutions helps life sciences organizations accelerate clinical development initiatives. Various eClinical solutions help effectively manage and integrate data generated during clinical trials. eClinical solutions include tools to effectively plan, manage, track clinical study portfolios, and create insights. Increasing research and development (R&D) activities by biopharma and biopharma companies are expanding the usage of eClinical solutions. In addition, the rising utilization of advanced technologies, including the IoT and AI, in the healthcare sector increases the amount of data produced, elevating the demand for eClinical solutions. High implementation costs and security & privacy concerns associated with eClinical solutions impede the market's growth. The introduction of technologically advanced eClinical solutions by market vendors is expected to fuel the development of the eClinical solutions market.

Regional Insights

The Americas represents a highly developing and innovative landscape for the global eClinical solutions market characterized by rising awareness and market players' increasing introduction of advanced eClinical solution platforms. For instance, in May 2022, eClinical Solutions LLC launched an elluminate Statistical Computing Environment (SCE) expanding Clinical Data Cloud platform that integrates and unifies clinical trial data. Significant governmental initiatives and investments to expand biotechnology research and development with advanced analytical equipment are expected to foster the growth of the eClinical solutions market. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to increase investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The eClinical solutions market witnessed substantial growth in Europe, the middle east, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's life science sector contributes more than USD 66 billion and provide 220,000 jobs annually to the UK economy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the eClinical Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the eClinical Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the eClinical Solutions Market, highlighting leading vendors and their innovative profiles. These include 4G Clinical, Acceliant, Advarra, Inc., Anju Software, Inc., ArisGlobal LLC, BSI Business Systems Integration AG, Castor Research Inc., Clinion, Dassault Systèmes S.E., DataTrak International, Inc., eClinical Solutions LLC, eResearchTechnology, Inc. by Clario, EvidentIQ Group GmbH, ICON PLC, International Business Machines Corporation, IQVIA Inc., KPS Life, LLC, MaxisIT Inc., MedNet, Medrio, Inc., Microsoft Corporation, Octalsoft, Oracle Corporation, Parexel International Corporation, RealTime Software Solutions, LLC, ResoluteAI, Saama Technologies, LLC, Signant Health, and Veeva Systems Inc.

Market Segmentation & Coverage

This research report categorizes the eClinical Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Clinical Analytics Platforms
    • Clinical Data Integration Platforms
    • CTMS
    • ECOA
    • EDC & CDMS
    • eTMF
    • RTSM
    • Safety Solutions
  • Development Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Delivery Mode
    • Cloud-Based
    • Licensed Enterprise
    • Web-Hosted
  • End-User
    • Academic Institutes
    • CROs
    • Hospitals
    • Medical Device Manufacturers
    • Pharma & Biotech Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the eClinical Solutions Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the eClinical Solutions Market?
  3. What are the technology trends and regulatory frameworks in the eClinical Solutions Market?
  4. What is the market share of the leading vendors in the eClinical Solutions Market?
  5. Which modes and strategic moves are suitable for entering the eClinical Solutions Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. eClinical Solutions Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising research and development activities by pharma and biopharma companies
5.1.1.2. Increasing integration of IoT and AI in the pharmaceutical sector
5.1.1.3. Presence of a stringent regulatory structure for clinical trials
5.1.2. Restraints
5.1.2.1. High cost of implementation of eClinical solutions
5.1.3. Opportunities
5.1.3.1. Introduction of technologically advanced eClinical solutions
5.1.3.2. Increasing incorporation of software in eClinical solutions
5.1.4. Challenges
5.1.4.1. Software reliability and patent privacy issues associated with eClinical solutions
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. eClinical Solutions Market, by Product
6.1. Introduction
6.2. Clinical Analytics Platforms
6.3. Clinical Data Integration Platforms
6.4. CTMS
6.5. ECOA
6.6. EDC & CDMS
6.7. eTMF
6.8. RTSM
6.9. Safety Solutions
7. eClinical Solutions Market, by Development Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. eClinical Solutions Market, by Delivery Mode
8.1. Introduction
8.2. Cloud-Based
8.3. Licensed Enterprise
8.4. Web-Hosted
9. eClinical Solutions Market, by End-User
9.1. Introduction
9.2. Academic Institutes
9.3. CROs
9.4. Hospitals
9.5. Medical Device Manufacturers
9.6. Pharma & Biotech Organizations
10. Americas eClinical Solutions Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific eClinical Solutions Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa eClinical Solutions Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. CapVest's GLO Healthcare Completes Acquisition of Calyx, a Global Leader in the Delivery of Improved Outcomes From Clinical Trials
13.3.1.2. RealTime Software Solutions Acquires Complion
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Almac Introduces IXRS3 Partnership Network
13.3.2.2. Evidentiq and Dacima Software of Canada join forces to offer end-to-end software for clinical trials
13.3.2.3. Full-service CRO LINK Medical and Viedoc sign a new partnership agreement
13.3.3. New Product Launch & Enhancement
13.3.3.1. Clinion Launches Revolutionary AI-Powered Medical Coding Solution for Clinical Trials
13.3.3.2. ResoluteAI Launches Clinical Trial Analytics
13.3.4. Investment & Funding
13.3.4.1. eClinicalWorks Invests USD 100 Million in Microsoft Cloud Services
13.3.4.2. Curebase Secures USD 40 Million in Series B Funding
13.3.5. Award, Recognition, & Expansion
13.3.5.1. eClinical Solutions Expands Presence and Growth on West Coast as Market Continues to Grow
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 4G Clinical
14.1.2. Acceliant
14.1.3. Advarra, Inc.
14.1.4. Anju Software, Inc.
14.1.5. ArisGlobal LLC
14.1.6. BSI Business Systems Integration AG
14.1.7. Castor Research Inc.
14.1.8. Clinion
14.1.9. Dassault Systèmes S.E.
14.1.10. DataTrak International, Inc.
14.1.11. eClinical Solutions LLC
14.1.12. eResearchTechnology, Inc. by Clario
14.1.13. EvidentIQ Group GmbH
14.1.14. ICON PLC
14.1.15. International Business Machines Corporation
14.1.16. IQVIA Inc.
14.1.17. KPS Life, LLC
14.1.18. MaxisIT Inc.
14.1.19. MedNet
14.1.20. Medrio, Inc.
14.1.21. Microsoft Corporation
14.1.22. Octalsoft
14.1.23. Oracle Corporation
14.1.24. Parexel International Corporation
14.1.25. RealTime Software Solutions, LLC
14.1.26. ResoluteAI
14.1.27. Saama Technologies, LLC
14.1.28. Signant Health
14.1.29. Veeva Systems Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ECLINICAL SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. ECLINICAL SOLUTIONS MARKET SIZE, 2022 VS 2030
FIGURE 3. ECLINICAL SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. ECLINICAL SOLUTIONS MARKET DYNAMICS
FIGURE 7. ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2022 VS 2030 (%)
FIGURE 10. ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2022 VS 2030 (%)
FIGURE 12. ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. ECLINICAL SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. ECLINICAL SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL ANALYTICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL DATA INTEGRATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ECLINICAL SOLUTIONS MARKET SIZE, BY CTMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ECLINICAL SOLUTIONS MARKET SIZE, BY ECOA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ECLINICAL SOLUTIONS MARKET SIZE, BY EDC & CDMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ECLINICAL SOLUTIONS MARKET SIZE, BY ETMF, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ECLINICAL SOLUTIONS MARKET SIZE, BY RTSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ECLINICAL SOLUTIONS MARKET SIZE, BY SAFETY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 15. ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 20. ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ECLINICAL SOLUTIONS MARKET SIZE, BY LICENSED ENTERPRISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ECLINICAL SOLUTIONS MARKET SIZE, BY WEB-HOSTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. ECLINICAL SOLUTIONS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. ECLINICAL SOLUTIONS MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. ECLINICAL SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. ECLINICAL SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. ECLINICAL SOLUTIONS MARKET SIZE, BY PHARMA & BIOTECH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 44. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 45. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 66. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 67. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 70. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 71. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 79. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 103. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 116. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 120. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 139. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 140. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 152. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 155. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 156. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 159. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 160. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 176. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 188. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 198. ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 199. ECLINICAL SOLUTIONS MARKET LICENSE & PRICING

Companies Mentioned

  • 4G Clinical
  • Acceliant
  • Advarra, Inc.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • BSI Business Systems Integration AG
  • Castor Research Inc.
  • Clinion
  • Dassault Systèmes S.E.
  • DataTrak International, Inc.
  • eClinical Solutions LLC
  • eResearchTechnology, Inc. by Clario
  • EvidentIQ Group GmbH
  • ICON PLC
  • International Business Machines Corporation
  • IQVIA Inc.
  • KPS Life, LLC
  • MaxisIT Inc.
  • MedNet
  • Medrio, Inc.
  • Microsoft Corporation
  • Octalsoft
  • Oracle Corporation
  • Parexel International Corporation
  • RealTime Software Solutions, LLC
  • ResoluteAI
  • Saama Technologies, LLC
  • Signant Health
  • Veeva Systems Inc.

Methodology

Loading
LOADING...

Table Information